首页 > 市场调查报告书 > 医疗设备

生技设备

寡核苷酸合成设备市场规模、份额和成长分析：按类型、技术、外形规格、应用、最终用户和地区划分－2026-2033年产业预测

市场调查报告书

商品编码

1964197

寡核苷酸合成设备市场规模、份额和成长分析：按类型、技术、外形规格、应用、最终用户和地区划分－2026-2033年产业预测

Oligonucleotide Synthesizer Market Size, Share, and Growth Analysis, By Type, By Technology, By Form Factor, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2024年全球寡核苷酸合成设备市场价值为18.2亿美元，预计将从2025年的20亿美元成长到2033年的43.2亿美元。预测期（2026-2033年）的复合年增长率预计为10.09%。

全球寡核苷酸合成设备市场正快速扩张，其主要驱动力是科学研究、诊断和治疗领域对精准核酸工具日益增长的需求。基因编辑、反义疗法和mRNA疫苗研发对合成寡核苷酸的需求不断增长，推动了这一成长。合成寡核苷酸在将分子序列转化为药物研发和临床诊断的可操作解决方案方面发挥着至关重要的作用。自动化和固相化学技术的进步正推动产业朝向分散式桌上型合成系统发展，从而缩短处理时间并降低成本。这项转变凸显了对能够生产高纯度、大规模文库的高通量、可靠合成设备日益增长的需求，并促进了自动化纯化和品质监控领域的创新。因此，这一趋势正在推动设备销售、服务多元化、策略合作，并创造新的商业性机会。

全球寡核苷酸合成设备市场驱动因素

寡核苷酸疗法的需求日益增长，推动了合成设备技术的投资，促使製造商提升产能并扩大产品线。可靠且柔软性的合成平台对于临床和临床前研究至关重要，因此增加了设备的采购和升级需求。这种需求的成长迫使供应商专注于优化通量、缩短週转时间和提高可重复性，从而增强研究人员和生物製药公司的信心。因此，这种互动形成了一个良性循环，透过促进技术的持续应用和技术进步，推动市场持续成长，并加强商业和研究合作。

全球寡核苷酸合成设备市场的限制因素

全球寡核苷酸合成设备市场面临一个重大障碍：先进合成设备需要高额的初始资本投入。这可能会阻碍小规模实验室和新兴生物技术公司做出此类财务承诺。这项投资往往会与其他关键研究项目产生衝突，导致潜在买家推迟采购，转而选择外包或使用较旧的技术。因此，製造商难以向注重预算的客户证明其产品的长期价值，因为这些客户无法立即看到降低营运成本的好处。这种情况导致资金雄厚的机构主导市场，限制了整体市场成长，并阻碍了创新技术的快速普及。

全球寡核苷酸合成设备市场趋势

全球寡核苷酸合成设备市场正经历着由先进自动化和机器人技术应用驱动的显着成长趋势。这项技术进步实现了高通量生产和更短的生产週期，使企业能够优化生产流程。投资模组化、软体驱动的平台能够提升通讯协定的标准化和可重复性，支援批量规模的扩充性，同时确保产品品质。因此，製造商能够更好地适应市场需求的波动，并促进与合约开发人员的合作。此外，自动化减少了对熟练人工的依赖，增强了营运的韧性，使专业人员能够专注于寡核苷酸合成领域的创新发展。

北美洲
- 我们
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场公司采取的策略
近期市场趋势
企业市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 按细分市场进行企业市占率分析
- 2023-2025年营收年比比较

主要企业简介

Thermo Fisher Scientific
Agilent Technologies
Integrated DNA Technologies
Eurofins Genomics
Sigma-Aldrich
Biolegio
GenScript
Fasmac
OligoSupply
Primedice
Twist Bioscience
Synthego
Bioneer
Nanjing GenScript
Vazyme
TriLink BioTechnologies
ChemGenes
LGC Biosearch Technologies
QIAGEN
Merck KGaA

结论与建议

简介目录

Product Code: SQMIG35J2200

Global Oligonucleotide Synthesizer Market size was valued at USD 1.82 Billion in 2024 and is poised to grow from USD 2.0 Billion in 2025 to USD 4.32 Billion by 2033, growing at a CAGR of 10.09% during the forecast period (2026-2033).

The global oligonucleotide synthesizer market is expanding rapidly due to an increased need for precise nucleic acid tools used in research, diagnostics, and therapeutics. The demand for synthesized oligos, critical for gene editing, antisense therapies, and mRNA vaccine development, propels this growth as they transform molecular sequences into practical solutions for drug discovery and clinical diagnostics. The industry has evolved towards decentralized benchtop synthesizers thanks to advancements in automation and solid-phase chemistry, resulting in reduced turnaround times and costs. This shift emphasizes the rising need for higher-throughput, reliable synthesizers capable of producing large libraries with high purity, thereby prompting innovation in automated purification and quality monitoring. Consequently, this trend fosters instrument sales, service diversification, and strategic partnerships, leading to new commercial opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oligonucleotide Synthesizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oligonucleotide Synthesizer Market Segments Analysis

Global oligonucleotide synthesizer market is segmented by type, technology, form factor, application, end-user and region. Based on type, the market is segmented into Standard Synthesizers, High-Throughput Synthesizers, Custom Synthesizers and Integrated Synthesizers. Based on technology, the market is segmented into Solid-Phase Synthesis, Liquid-Phase Synthesis, Microarray Technology and Polymerase Chain Reaction (PCR)-Based Methods. Based on form factor, the market is segmented into Bench-top Synthesizers, Portable Synthesizers, Modular Synthesizers and Automated Synthesizers. Based on application, the market is segmented into Research & Development, Diagnostic Applications, Therapeutic Applications and Forensic Applications. Based on end-user, the market is segmented into Academic Institutions, Pharmaceutical Companies, Biotechnology Firms and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oligonucleotide Synthesizer Market

The increasing demand for oligonucleotide-based therapeutics has spurred investments in synthesizer technologies, prompting manufacturers to enhance their production capabilities and diversify their product offerings. Reliable and flexible synthesis platforms are essential for clinical and preclinical programs, which fuels the need for purchases and upgrades. This heightened demand compels vendors to focus on optimizing throughput, minimizing turnaround times, and improving reproducibility, thereby instilling confidence in researchers and biopharmaceutical companies. Consequently, this interplay generates a positive feedback loop, promoting ongoing adoption and technological advancements that drive continuous market growth and strengthen commercial and research collaborations.

Restraints in the Global Oligonucleotide Synthesizer Market

The Global Oligonucleotide Synthesizer market faces significant barriers due to the high initial capital investment associated with advanced synthesizers, which can deter smaller laboratories and emerging biotech companies from making such financial commitments. This investment often competes with other critical research priorities, causing potential buyers to delay procurement and opt for outsourcing or older technologies instead. As a result, manufacturers encounter difficulties in demonstrating the long-term value of their products to budget-conscious customers who do not immediately see operational savings. Consequently, this scenario creates a market landscape dominated by well-funded institutions, limiting overall expansion and hindering the rapid adoption of innovative technologies.

Market Trends of the Global Oligonucleotide Synthesizer Market

The Global Oligonucleotide Synthesizer market is experiencing a significant trend driven by the adoption of advanced automation and robotics. This technological evolution facilitates high-throughput manufacturing and shorter cycle times, allowing firms to streamline production processes. Investment in modular, software-driven platforms enhances protocol standardization and reproducibility, supporting scalable batch sizes without compromising quality. Consequently, manufacturers are better equipped to adapt to fluctuating demand and foster collaboration with contract developers. Furthermore, automation reduces reliance on specialized manual labor, thereby bolstering operational resilience and enabling skilled professionals to focus on innovative advancements in oligonucleotide synthesis.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Oligonucleotide Synthesizer Market Size by Type & CAGR (2026-2033)

Market Overview
Standard Synthesizers
High-Throughput Synthesizers
Custom Synthesizers
Integrated Synthesizers

Global Oligonucleotide Synthesizer Market Size by Technology & CAGR (2026-2033)

Market Overview
Solid-Phase Synthesis
Liquid-Phase Synthesis
Microarray Technology
Polymerase Chain Reaction (PCR)-Based Methods

Global Oligonucleotide Synthesizer Market Size by Form Factor & CAGR (2026-2033)

Market Overview
Bench-top Synthesizers
Portable Synthesizers
Modular Synthesizers
Automated Synthesizers

Global Oligonucleotide Synthesizer Market Size by Application & CAGR (2026-2033)

Market Overview
Research & Development
Diagnostic Applications
Therapeutic Applications
Forensic Applications

Global Oligonucleotide Synthesizer Market Size by End-User & CAGR (2026-2033)

Market Overview
Academic Institutions
Pharmaceutical Companies
Biotechnology Firms
Diagnostic Laboratories

Global Oligonucleotide Synthesizer Market Size & CAGR (2026-2033)

North America (Type, Technology, Form Factor, Application, End-User)
- US
- Canada
Europe (Type, Technology, Form Factor, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Technology, Form Factor, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Technology, Form Factor, Application, End-User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Technology, Form Factor, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biolegio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fasmac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OligoSupply
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Primedice
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioneer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nanjing GenScript
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vazyme
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriLink BioTechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ChemGenes
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Biosearch Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments